Arkolith/Insider Trading/DRNA/Form 4

Ciappenelli Robert D.

Chief Strategy OfficerDicerna Pharmaceuticals Inc (DRNA) · full profile →Form 4 · filed Dec 29, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
1 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 28, 2021Tender(U)15K$38.25$567K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 28, 2021Disposed to issuer(D)10K——0
Dec 28, 2021Disposed to issuer(D)17K——0
Dec 28, 2021Disposed to issuer(D)62K——0
Dec 28, 2021Disposed to issuer(D)76K——0
Dec 28, 2021Disposed to issuer(D)270K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001399529-21-000196) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML